Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy

Digestive and Liver Disease

Volumn 44, Issue 12, 2012, Pages 1027-1031

  Jain, Lokesh ^a   Sharma, Barjesh Chander ^a   Sharma, Praveen ^b   Srivastava, Siddharth ^a   Agrawal, Amit ^a   Sarin, Shiv Kumar ^b  

^a G B PANT HOSPITAL   (India)

^b INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

Author keywords

IL 18; IL 6; TNF alpha

Indexed keywords

AMMONIA; ENDOTOXIN; INTERLEUKIN 18; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AMMONIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENDOTOXINS; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; INTERLEUKIN-18; INTERLEUKIN-6; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84868304337     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.07.002     Document Type: Article

References (30)

1. Balata S., Damink S.W., Ferguson K., et al. Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology 2003, 37:931-939.
2. Shawcross D.L., Davies N.A., Williams R., et al. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. Journal of Hepatology 2004, 40:247-254.
3. Shawcross D.L., Wright G., Olde S.W., et al. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metabolic Brain Disease 2007, 22:125-138.
4. Wright G., Jalan R. Ammonia and inflammation in the pathogenesis of hepatic encephalopathy: Pandora's box. Heoatology 2007, 46:291-294.
5. Nolan J.P. The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology 2010, 52:1829-1835.
6. Butterworth R.F. Hepatic encephalopathy: a central neuroinflammatory disorder. Hepatology 2011, 53:1372-1376.
7. Cauli O., Rodrigo R., Piedrafita B., et al. Neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: ibuprofen restores its motor activity. Journal of Neurosciences Research 2009, 87:1369-1374.
8. Cauli O., Rodrigo R., Piedrafita B., et al. Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. Hepatology 2007, 46:514-519.
9. Odeh M., Sabo E., Srugo I., et al. Relationship between TNF-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure. Annals of Medicine 2005, 37:603-612.
10. Lee M.D., Zentella A., Pekalla P.H., et al. Effect of endotoxin induced monokines on glucose metabolism in the muscle cell line L6. Proceedings of the National Academy of Sciences of the United States of America 1987, 84:2590-2594.
11. Darling G., Goldstein D.S., Stull R., et al. Tumor necrosis factor: immune endocrine interaction. Surgery 1989, 106:1155-1160.
12. Nagaki M., Iwai H., Naiki T., et al. High levels of serum interleukin-10 and tumor necrosis factor-α are associated with fatality in fulminant hepatitis. Journal of Infectious Diseases 2000, 182:1103-1108.
13. Rolando N., Ellis A.J., De Groote D., et al. Correlation of serial cytokine levels with progression to coma (grade IV) in patients with acute liver failure (ALF). Hepatology 1995, 22:366A.
14. Odeh M., Sabo E., Srugo I., et al. Serum levels of tumor necrosis factor-α correlate with severity of Hepatic encephalopathy due to chronic liver failure. Liver International 2004, 24:110-116.
15. Goral V., Atayan Y., Kaplan A. The relation between pathogenesis of liver cirrhosis, hepatic encephalopathy and serum cytokine levels: what is the role of tumor necrosis factor alpha?. Hepato-Gastroenterology 2011, 58:943-948.
16. Montoliu C., Piedrafita B., Serra M.A., et al. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. Journal of Clinical Gastroenterology 2009, 43:272-279.
17. Butterworth R.F. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metabolic Brain Disease 2002, 17:221-227.
18. Schenker S., Brady C.E. Pathogenesis of hepatic encephalopathy. Hepatic encephalopathy: syndromes and therapies 1994, 44-61. Med-Ed Press, Bloomington, IL. H.O. Conn, J. Bircher (Eds.).
19. Wright G., Davies N.A., Shawcross D.L., et al. Endotoxemia produces coma and brain swelling in bile duct ligated rats. Hepatology 2007, 45:1517-1526.
20. Odeh M. Pathogenesis of hepatic encephalopathy: the tumour necrosis factor-α theory. European Journal of Clinical Investigation 2007, 37:291-304.
21. Odeh M. Endotoxin and tumor necrosis factor-[alpha] in the pathogenesis of hepatic encephalopathy. Journal of Clinical Gastroenterology 1994, 19:146-153.
22. Krabbe K.S., Reichenberg A., Yirmiya R., et al. Low dose endotoxemia and human neuropsychological functions. Brain, Behavior, and Immunity 2005, 19:453-460.
23. Duchini A., Govindrajan S., Santucci M., et al. Effects of tumor necrosis factor-α and interleukin-6 on fluid phase permeability and ammonia diffusion in CNS derived endothelial cells. Journal of Investigative Medicine 1996, 44:474-482.
24. Pedersen H.R., Ring-Larsen H., Olsen N.V., et al. Hyperammonemia acts synergistically with lipopolysaccharide in inducing changes in cerebral hemodynamics in rats anesthetized with pentobarbital. Journal of Hepatology 2007, 47:245-252.
25. Ong J.P., Aggarwal A., Krieger D., et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. American Journal of Medicine 2003, 114:188-193.
26. Liu Q., Duan Z.P., Ha D.K., et al. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004, 39:1441-1449.
27. Marini J.C., Broussard S.R. Hyperammonemia increases sensitivity to LPS. Molecular Genetics and Metabolism 2006, 88:131-137.
28. Rodrigo R., Cauli O., Gomez-Pinedo U., et al. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 2010, 139:675-684.
29. Ahboucha S., Jiang W., Chatauret N., et al. Indomethacin improves locomotor deficit and reduces brain concentrations of neuroinhibitory steroids in rats following portacaval anastomosis. Neurogastroenterology Motility 2008, 20:949-957.
30. Agusti A., Cauli O., Rodrigo R., et al. p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts. Gut 2011, 60:1572-1579.